Embryonal rhabdomyosarcoma of the urogenital tract in childhood.

18 children, 12 boys and 6 girls, were treated in our hospital for rhabdomyosarcoma of the urogenital tract between 1970 and 1980. This period saw a gradual change in the therapeutic approach to this disease as new therapeutic modalities became available. 7 of the patients (39%) died of the disease which, in 5 of them, arose from the prostate. The surviving children have no evidence of recurrent disease, although 1 is still undergoing chemotherapy. Surgical intervention was always required. To date, chemotherapy alone, or in combination with radiation, has not sufficed in our management of rhabdomyosarcoma of the urogenital tract.